bazedoxifene has been researched along with Dyspareunia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pinkerton, JV | 1 |
| Goldstein, SR | 1 |
| Pinkerton, JV; Thomas, S | 1 |
| Komm, BS; Mirkin, S; Pickar, JH; Pinkerton, JV; Ryan, KA; Yu, CR | 1 |
| Crider, M; Hill, DA; Hill, SR | 1 |
3 review(s) available for bazedoxifene and Dyspareunia
| Article | Year |
|---|---|
Tissue-selective Estrogen Complex for Menopausal Hormone Therapy.
Topics: Bone Density; Breast Density; Dyspareunia; Endometrium; Estrogens; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Selective Estrogen Receptor Modulators; Sleep Initiation and Maintenance Disorders; Thromboembolism | 2018 |
Use of SERMs for treatment in postmenopausal women.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dyspareunia; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Osteoporosis; Osteoporosis, Postmenopausal; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Toremifene | 2014 |
Hormone Therapy and Other Treatments for Symptoms of Menopause.
Topics: Acupuncture Therapy; Administration, Intravaginal; Amines; Antidepressive Agents; Atrophy; Cyclohexanecarboxylic Acids; Dietary Supplements; Drug Therapy, Combination; Dyspareunia; Estrogen Replacement Therapy; Estrogens; Exercise Therapy; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypnosis; Indoles; Menopause; Paroxetine; Progestins; Selective Estrogen Receptor Modulators; Tamoxifen; Vagina; Vaginal Diseases; Vasomotor System; Venlafaxine Hydrochloride | 2016 |
1 trial(s) available for bazedoxifene and Dyspareunia
| Article | Year |
|---|---|
Conjugated estrogens and bazedoxifene in minority populations: pooled analysis of four phase 3 trials.
Topics: Black or African American; Bone Density; Double-Blind Method; Dyspareunia; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hispanic or Latino; Hot Flashes; Humans; Hydrogen-Ion Concentration; Indoles; Middle Aged; Minority Groups; Placebos; Postmenopause; Quality of Life; Selective Estrogen Receptor Modulators; Vagina; White People | 2016 |
1 other study(ies) available for bazedoxifene and Dyspareunia
| Article | Year |
|---|---|
Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogens.
Topics: Animals; Drug Combinations; Drug Labeling; Dyspareunia; Estrogens; Estrogens, Conjugated (USP); Female; Haplorhini; Humans; Indoles; Osteoporosis; Postmenopause; Selective Estrogen Receptor Modulators | 2014 |